![Albuterol Sulfate Inhalation Solution0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL)(*Potency expressed as albuterol, equivalent to 1.5 mgand 0.75 mg albuterol sulfate) Revised: January 2017 Rx only Albuterol Sulfate Inhalation Solution0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL)(*Potency expressed as albuterol, equivalent to 1.5 mgand 0.75 mg albuterol sulfate) Revised: January 2017 Rx only](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-8.jpg&id=427002)
Albuterol Sulfate Inhalation Solution0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL)(*Potency expressed as albuterol, equivalent to 1.5 mgand 0.75 mg albuterol sulfate) Revised: January 2017 Rx only
![PDF] The conversion to metered-dose inhaler with valved holding chamber to administer inhaled albuterol: a pediatric hospital experience. | Semantic Scholar PDF] The conversion to metered-dose inhaler with valved holding chamber to administer inhaled albuterol: a pediatric hospital experience. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c68aa2399ed2c2fdcb1c686e8756eb6af886514e/6-Table4-1.png)
PDF] The conversion to metered-dose inhaler with valved holding chamber to administer inhaled albuterol: a pediatric hospital experience. | Semantic Scholar
![PDF) Paradoxical Bronchoconstriction with Albuterol Administered by Metered- Dose Inhaler and Nebulizer Solution PDF) Paradoxical Bronchoconstriction with Albuterol Administered by Metered- Dose Inhaler and Nebulizer Solution](https://www.researchgate.net/profile/Jacqueline-Olin-2/publication/7588706/figure/tbl1/AS:601759449903122@1520482041768/Summary-of-Published-Case-Reports-Describing-Paradoxical-Bronchoconstriction-with_Q320.jpg)
PDF) Paradoxical Bronchoconstriction with Albuterol Administered by Metered- Dose Inhaler and Nebulizer Solution
![PDF] Albuterol aerosol delivered via metered-dose inhaler to intubated pediatric models of 3 ages, with 4 spacer designs. | Semantic Scholar PDF] Albuterol aerosol delivered via metered-dose inhaler to intubated pediatric models of 3 ages, with 4 spacer designs. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a4ba725b7e3c0b3f14d07b7d5acf5a487a0af235/2-Table1-1.png)
PDF] Albuterol aerosol delivered via metered-dose inhaler to intubated pediatric models of 3 ages, with 4 spacer designs. | Semantic Scholar
![PDF] The conversion to metered-dose inhaler with valved holding chamber to administer inhaled albuterol: a pediatric hospital experience. | Semantic Scholar PDF] The conversion to metered-dose inhaler with valved holding chamber to administer inhaled albuterol: a pediatric hospital experience. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c68aa2399ed2c2fdcb1c686e8756eb6af886514e/5-Table1-1.png)
PDF] The conversion to metered-dose inhaler with valved holding chamber to administer inhaled albuterol: a pediatric hospital experience. | Semantic Scholar
![PDF] Nebulizers vs metered-dose inhalers with spacers for bronchodilator therapy to treat wheezing in children aged 2 to 24 months in a pediatric emergency department. | Semantic Scholar PDF] Nebulizers vs metered-dose inhalers with spacers for bronchodilator therapy to treat wheezing in children aged 2 to 24 months in a pediatric emergency department. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1fef1372be98e8bfb5ba78f8f8f8f6b8feef9b7a/3-Table2-1.png)